. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Feb 22;156(1):440–448.e2. doi: 10.1016/j.jtcvs.2018.01.101

Table 2.

Health-Related Quality of Life before Lung Transplantation

	ECMO n=17	Inpatient n=48	Outpatient n=124	Whole Cohort n=189	p-value

SF12-PCS (MCID=5)	24.7 ± 6.8	21.7 ± 8.0	23.3 ± 7.9	23.0 ± 7.8	0.35
SF12-MCS (MCID=5)	43.9 ± 11.1	45.3 ± 10.0	49.5 ± 9.9	48.0 ± 10.3	0.01
AQ20R (MCID=1.75)	6.1 ± 3.3	6.2 ± 3.7	6.2 ± 3.4	6.2 ± 3.4	0.99
EQ5D (MCID=0.06)	0.51 ± 0.29	0.53 ± 0.19	0.68 ± 0.17	0.62 ± 0.21	<0.001
GDS (MCID=1.65)	7.9 ± 3.3	8.9 ± 3.3	9.2 ± 3.3	9.0 ± 3.3	0.33

Data presented as unadjusted mean score ± standard deviation.

HRQL Instruments: Generic Physical Instrument: SF12-PCS (Short Form 12 – Physical Component Score) Range 0–100; Generic Mental Instrument: SF12-MCS (Short Form 12 – Mental Component Score) Range 0–100; Respiratory-Specific Instrument: AQ20R (Airways Questionnaire 20-Revised) Range 0–20 – reverse coded for analysis; Health-Utility Instrument: EQ5D (EuroQoL 5D) Range −1.11 – 1; Depression Scale: GDS (Geriatric Depression Scale) Range: 0–15 – reverse coded for analysis